Literature DB >> 19856417

Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy.

Yuchi Han1, Dana C Peters, Basem Dokhan, Warren J Manning.   

Abstract

PURPOSE: To find evidence of diffuse fibrosis in dilated cardiomyopathy (DCM) patients by comparing measurements on clinical late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) studies between DCM and healthy subjects.
MATERIALS AND METHODS: LGE-CMR and the Look-Locker images from 20 DCM patients and 17 healthy controls were analyzed. Blood signal-to-noise ratio (SNR), myocardium SNR, and blood-to-myocardium contrast-to-noise ratio (CNR) were measured on the LGE-CMR images. The optimal inversion time (TI) to null blood and myocardium was determined on the Look-Locker images. The postcontrast T(1) was estimated using a phantom study that correlated optimal TI and heart rate to T(1).
RESULTS: The blood SNR was lower, myocardium SNR was higher, and the blood-to-myocardium CNR was lower (6.6 +/- 0.7 vs. 10.3 +/- 0.9, P = 0.004) on DCM LGE-CMR images as compared to controls. The blood-myocardium optimal TI difference (DeltaTI) was lower (38 +/- 2 msec vs. 55 +/- 3 msec, P < 0.001) in DCM, and the estimated blood-myocardium T(1) difference (DeltaT(1)) (116 +/- 6 msec vs. 152 +/- 8 msec, P = 0.001) was also lower.
CONCLUSION: DCM patients have reduced blood-myocardium DeltaTI and DeltaT(1), and lower CNR as compared to controls, suggesting the presence of diffuse fibrosis. This may impact the interpretation of LGE data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856417      PMCID: PMC2862561          DOI: 10.1002/jmri.21953

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy.

Authors:  Oliver Zimmermann; Olaf Grebe; Nico Merkle; Thorsten Nusser; Matthias Kochs; Magdalena Bienek-Ziolkowski; Vinzenz Hombach; Jan Torzewski
Journal:  Eur J Heart Fail       Date:  2005-08-19       Impact factor: 15.534

2.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

3.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

Review 4.  Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).

Authors:  Matthias Vöhringer; Heiko Mahrholdt; Ali Yilmaz; Udo Sechtem
Journal:  Herz       Date:  2007-03       Impact factor: 1.443

5.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

6.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

7.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy.

Authors:  Michael Jerosch-Herold; David C Sheridan; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Diana Dutton; Rami Alharethi; Duanxiang Li; Ray E Hershberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

8.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Authors:  Katherine C Wu; Robert G Weiss; David R Thiemann; Kakuya Kitagawa; André Schmidt; Darshan Dalal; Shenghan Lai; David A Bluemke; Gary Gerstenblith; Eduardo Marbán; Gordon F Tomaselli; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-06-24       Impact factor: 24.094

9.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.

Authors:  Steffen Bohl; Ralf Wassmuth; Hassan Abdel-Aty; André Rudolph; Daniel Messroghli; Rainer Dietz; Jeanette Schulz-Menger
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-16       Impact factor: 2.357

10.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  11 in total

1.  Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences.

Authors:  Marcelo Souto Nacif; Evrim B Turkbey; Neville Gai; Saman Nazarian; Rob J van der Geest; Radwa A Noureldin; Christopher T Sibley; Martin Ugander; Songtao Liu; Andrew E Arai; João A C Lima; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2011-09-23       Impact factor: 4.813

2.  Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT.

Authors:  Marcelo Souto Nacif; Nadine Kawel; Jason J Lee; Xinjian Chen; Jianhua Yao; Anna Zavodni; Christopher T Sibley; João A C Lima; Songtao Liu; David A Bluemke
Journal:  Radiology       Date:  2012-07-06       Impact factor: 11.105

Review 3.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

4.  Alström syndrome: cardiac magnetic resonance findings.

Authors:  Francesco Corbetti; Renato Razzolini; Vera Bettini; Jan D Marshall; Jürgen Naggert; Francesco Tona; Gabriella Milan; Pietro Maffei
Journal:  Int J Cardiol       Date:  2012-04-10       Impact factor: 4.164

5.  Cardiac magnetic resonance T1 mapping of left atrial myocardium.

Authors:  Roy Beinart; Irfan M Khurram; Songtao Liu; Hirad Yarmohammadi; Henry R Halperin; David A Bluemke; Neville Gai; Rob J van der Geest; Joao A C Lima; Hugh Calkins; Stefan L Zimmerman; Saman Nazarian
Journal:  Heart Rhythm       Date:  2013-05-02       Impact factor: 6.343

Review 6.  Cardiac Computed Tomography - More Than Coronary Arteries? A Clinical Update.

Authors:  Jana Taron; Borek Foldyna; Parastou Eslami; Udo Hoffmann; Konstantin Nikolaou; Fabian Bamberg
Journal:  Rofo       Date:  2019-06-27

7.  Myocardial extracellular volume fraction quantification in an animal model of the doxorubicin-induced myocardial fibrosis: a synthetic hematocrit method using 3T cardiac magnetic resonance.

Authors:  Zhen Zhou; Rui Wang; Hui Wang; Yi Liu; Dongxu Lu; Zhonghua Sun; Guang Yang; Lei Xu
Journal:  Quant Imaging Med Surg       Date:  2021-02

8.  Myocardial extracellular volume fraction analysis in doxorubicin-induced beagle models: comparison of dual-energy CT with equilibrium contrast-enhanced single-energy CT.

Authors:  Zhen Zhou; Yifeng Gao; Hongwei Wang; Wenjing Wang; Hongkai Zhang; Sicong Wang; Zhonghua Sun; Lei Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

9.  The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy.

Authors:  Massimo Slavich; Anca Florian; Jan Bogaert
Journal:  Insights Imaging       Date:  2011-05-19

Review 10.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.